These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30309472)

  • 1. Home Monitoring for Fetal Heart Rhythm During Anti-Ro Pregnancies.
    Cuneo BF; Sonesson SE; Levasseur S; Moon-Grady AJ; Krishnan A; Donofrio MT; Raboisson MJ; Hornberger LK; Van Eerden P; Sinkovskaya E; Abuhamad A; Arya B; Szwast A; Gardiner H; Jacobs K; Freire G; Howley L; Lam A; Kaizer AM; Benson DW; Jaeggi E
    J Am Coll Cardiol; 2018 Oct; 72(16):1940-1951. PubMed ID: 30309472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Evaluation of High Titer Autoantibodies and Fetal Home Monitoring in the Detection of Atrioventricular Block Among Anti-SSA/Ro Pregnancies.
    Buyon JP; Masson M; Izmirly CG; Phoon C; Acherman R; Sinkovskaya E; Abuhamad A; Makhoul M; Satou G; Hogan W; Pinto N; Moon-Grady A; Howley L; Donofrio M; Krishnan A; Ahmadzia H; Levasseur S; Paul E; Owens S; Cumbermack K; Matta J; Joffe G; Lindblade C; Haxel C; Kohari K; Copel J; Strainic J; Doan T; Bermudez-Wagner K; Holloman C; Sheth SS; Killen S; Tacy T; Kaplinski M; Hornberger L; Carlucci PM; Izmirly P; Fraser N; Clancy RM; Cuneo BF
    Arthritis Rheumatol; 2024 Mar; 76(3):411-420. PubMed ID: 37947364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
    Mevorach D; Elchalal U; Rein AJ
    Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study.
    Rein AJ; Mevorach D; Perles Z; Gavri S; Nadjari M; Nir A; Elchalal U
    Circulation; 2009 Apr; 119(14):1867-72. PubMed ID: 19332471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart sounds at home: feasibility of an ambulatory fetal heart rhythm surveillance program for anti-SSA-positive pregnancies.
    Cuneo BF; Moon-Grady AJ; Sonesson SE; Levasseur S; Hornberger L; Donofrio MT; Krishnan A; Szwast A; Howley L; Benson DW; Jaeggi E
    J Perinatol; 2017 Mar; 37(3):226-230. PubMed ID: 27977016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Home fetal heart rate monitoring in anti Ro/SSA positive pregnancies: Literature review and case report.
    Milazzo R; Ligato E; Laoreti A; Ferri G; Basili L; Serati L; Brucato A; Cetin I
    Eur J Obstet Gynecol Reprod Biol; 2021 Apr; 259():1-6. PubMed ID: 33556767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing fetal cardiac conduction in anti-Ro/SSA-positive pregnancies.
    Sonesson SE; Hedlund M; Ambrosi A; Wahren-Herlenius M
    Rheumatology (Oxford); 2017 Oct; 56(10):1755-1762. PubMed ID: 28957562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies.
    Sonesson SE; Salomonsson S; Jacobsson LA; Bremme K; Wahren-Herlenius M
    Arthritis Rheum; 2004 Apr; 50(4):1253-61. PubMed ID: 15077309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome in 212 anti-Ro/SSA-positive pregnancies and population-based incidence of congenital heart block.
    Skog A; Lagnefeldt L; Conner P; Wahren-Herlenius M; Sonesson SE
    Acta Obstet Gynecol Scand; 2016 Jan; 95(1):98-105. PubMed ID: 26411741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of atrioventricular conduction by echocardiography and magnetocardiography in normal and anti-Ro/SSA-antibody-positive pregnancies.
    Cuneo BF; Bitant S; Strasburger JF; Kaizer AM; Wakai RT
    Ultrasound Obstet Gynecol; 2019 Nov; 54(5):625-633. PubMed ID: 30784137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of fetal echocardiographic surveillance in pregnancies at risk of congenital heart block: single-center study of 212 anti-Ro52-positive pregnancies.
    Sonesson SE; Ambrosi A; Wahren-Herlenius M
    Ultrasound Obstet Gynecol; 2019 Jul; 54(1):87-95. PubMed ID: 30620419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.
    Jaeggi E; Laskin C; Hamilton R; Kingdom J; Silverman E
    J Am Coll Cardiol; 2010 Jun; 55(24):2778-84. PubMed ID: 20538173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Ro52/SSA antibody-exposed fetuses with prolonged atrioventricular time intervals show signs of decreased cardiac performance.
    Bergman G; Eliasson H; Bremme K; Wahren-Herlenius M; Sonesson SE
    Ultrasound Obstet Gynecol; 2009 Nov; 34(5):543-9. PubMed ID: 19795521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal ECG: a novel predictor of atrioventricular block in anti-Ro positive pregnancies.
    Gardiner HM; Belmar C; Pasquini L; Seale A; Thomas M; Dennes W; Taylor MJ; Kulinskaya E; Wimalasundera R
    Heart; 2007 Nov; 93(11):1454-60. PubMed ID: 17085531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing the burden of surveillance in pregnant women with no history of fetal atrioventricular block using the negative predictive value of anti-Ro/SSA antibody titers.
    Kaizer AM; Lindblade C; Clancy R; Tebo AE; Drewes B; Masson M; Chang M; Fraser N; Buyon JP; Cuneo BF
    Am J Obstet Gynecol; 2022 Nov; 227(5):761.e1-761.e10. PubMed ID: 35690080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological characteristics of fetal atrioventricular block.
    Zhao H; Cuneo BF; Strasburger JF; Huhta JC; Gotteiner NL; Wakai RT
    J Am Coll Cardiol; 2008 Jan; 51(1):77-84. PubMed ID: 18174041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Polynomial Reference Ranges for Atrioventricular Intervals Assessed by Fetal Echocardiography in Anti-Ro/SSA Antibody-Positive Pregnancies to Exclude Fetal Heart Blocks: A Pilot Study.
    Mosimann B; Amylidi-Mohr S; Surbek D; Förger F; Raio L
    Fetal Diagn Ther; 2023; 50(6):422-429. PubMed ID: 37497922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causes of fetal third-degree atrioventricular block and use of hydroxychloroquine in pregnant women with Ro/La antibodies.
    Mollerach FB; Scolnik M; Catoggio LJ; Rosa J; Soriano ER
    Clin Rheumatol; 2019 Aug; 38(8):2211-2217. PubMed ID: 30997589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies.
    Skog A; Wahren-Herlenius M; Sundström B; Bremme K; Sonesson SE
    Pediatrics; 2008 Apr; 121(4):e803-9. PubMed ID: 18381509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.